Author： Cianfrocca Mary Gradishar William J.
Publisher： Cambridge Scholars Publishing in association with GSE Research
ISSN： 1540-1405
Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.5, Iss.8, 2007-09, pp. : 771-773
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Trastuzumab vs chemotherapy in metastatic breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 378, 2002-01 ,pp. :
Recent Developments in Treatment Stratification for Metastatic Breast Cancer
By Barton Sarah Swanton Charles
Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. :
Bevacizumab: In First-Line Treatment of Metastatic Breast Cancer
Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. :
New Therapeutic Options for Chemotherapy-Resistant Metastatic Breast Cancer: The Epothilones
Drugs, Vol. 68, Iss. 2, 2008-01 ,pp. :